Article
Clinical relevance of protein-truncating variants of germline DNA repair genes in prostate cancer.
BMC cancer - 25 Oct 2024
Shao Yu-Hsuan Joni, Liao Cai-Sian, Hsu Yu-Ching, Chiu Yu-Chiao, Lu Tsai-Jung, Ou Yen-Chuan, Hsiao Tzu-Hung
Abstract excerpt
BACKGROUND: Interpreting genetic variants remains a challenge in prostate cancer (PCa). Although many annotation tools are available for prioritizing causal variants, the clinical relevance of these variants is rarely studied. METHODS: We collected a cohort study that included 274 PCa patients from June 2017 to December 2020 and sequenced 19 DNA damage repair (DDR) genes in these patients and explored the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
